Author： Hale G.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.63, Iss.12, 2003-01, pp. : 1245-1246
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Frampton J.E. Wagstaff A.J.
Drugs, Vol. 63, Iss. 12, 2003-01 ,pp. :
Access to resources
Recommend
Alemtuzumab: Coagulopathy: case report
Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. :
Increased risk of infections with alemtuzumab?
Reactions Weekly, Vol. 1, Iss. 1109, 2006-01 ,pp. :
Alemtuzumab effective in MS, but at a cost
Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. :
Infection-related deaths with alemtuzumab consolidation
Reactions Weekly, Vol. 1, Iss. 1230, 2008-01 ,pp. :